Target intelligence / Profile preview

Intestinal epithelial cell surface attachment factors (IEC-SAFs)

Target
IEC-SAFs
Molecular classification
Glycoprotein, Glycolipid, Cell adhesion molecule, Receptor, Other
01

Overview

Intestinal epithelial cell surface attachment factors (IEC-SAFs) represent a broad category of host molecules, including glycoproteins, glycolipids, and cell adhesion molecules, that serve as docking sites for both commensal and pathogenic microorganisms. These factors, such as Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs), integrins, and various glycans, are critical for the initial colonization and subsequent invasion of the intestinal mucosa by pathogens like Enterotoxigenic Escherichia coli (ETEC) and Salmonella. In a healthy state, they facilitate the stable maintenance of the gut microbiota and mediate essential cell-cell signaling and barrier functions. In disease contexts, particularly enteric infections and inflammatory bowel diseases, these factors are exploited by pathogens to bypass host defenses or are dysregulated, leading to chronic inflammation. Therapeutic strategies targeting these factors often focus on anti-adhesion molecules or competitive inhibitors designed to prevent pathogen binding without disrupting the beneficial commensal population. This target entry is considered 'incorrect' in a strict sense because it describes a functional class of diverse molecules rather than a single, specific protein or receptor.

Other names
Enterocyte attachment receptorsIntestinal adhesion moleculesHost cell surface receptorsBacterial attachment factorsIntestinal glycoconjugates
02

Mechanism of action

Inhibition of microbial adhesion to host cell surface receptors, competitive binding to attachment sites, or modulation of host cell surface expression of adhesion molecules.

03

Biological functions

Cell-cell adhesionHost-pathogen interactionSignal transductionBarrier maintenanceImmune response
04

Disease associations

InfectionInflammationInflammatory bowel diseaseDiarrheal diseaseOther
05

Safety considerations

Disruption of commensal microbiotaPotential for systemic absorption of anti-adhesivesCompromise of intestinal barrier integrityOff-target binding to non-intestinal epithelia
06

Interacting drugs

Rifaximin

4 more in the full profile.

07

Biomarkers

CEACAM1 expressionMUC2 levelsFecal calprotectinStool pathogen load

Beyond the preview

Go deeper on Intestinal epithelial cell surface attachment factors (IEC-SAFs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal epithelial cell surface attachment factors (IEC-SAFs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call